584 related articles for article (PubMed ID: 32207237)
1. Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.
Watanabe M; Tozzi R; Risi R; Tuccinardi D; Mariani S; Basciani S; Spera G; Lubrano C; Gnessi L
Obes Rev; 2020 Aug; 21(8):e13024. PubMed ID: 32207237
[TBL] [Abstract][Full Text] [Related]
2. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
[TBL] [Abstract][Full Text] [Related]
3. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
Jani S; Da Eira D; Stefanovic M; Ceddia RB
J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
[TBL] [Abstract][Full Text] [Related]
4. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.
Luukkonen PK; Dufour S; Lyu K; Zhang XM; Hakkarainen A; Lehtimäki TE; Cline GW; Petersen KF; Shulman GI; Yki-Järvinen H
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7347-7354. PubMed ID: 32179679
[TBL] [Abstract][Full Text] [Related]
5. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences.
D'Abbondanza M; Ministrini S; Pucci G; Nulli Migliola E; Martorelli EE; Gandolfo V; Siepi D; Lupattelli G; Vaudo G
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32916989
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Ketogenic Diets with and without Ketone Salts versus a Low-Fat Diet: Liver Fat Responses in Overweight Adults.
Crabtree CD; Kackley ML; Buga A; Fell B; LaFountain RA; Hyde PN; Sapper TN; Kraemer WJ; Scandling D; Simonetti OP; Volek JS
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33802651
[TBL] [Abstract][Full Text] [Related]
7. Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses.
Ahn J; Jun DW; Lee HY; Moon JH
Clin Nutr; 2019 Oct; 38(5):2023-2030. PubMed ID: 30314924
[TBL] [Abstract][Full Text] [Related]
8. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
[TBL] [Abstract][Full Text] [Related]
9. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.
Schugar RC; Crawford PA
Curr Opin Clin Nutr Metab Care; 2012 Jul; 15(4):374-80. PubMed ID: 22617564
[TBL] [Abstract][Full Text] [Related]
10. Ketogenic diets for drug-resistant epilepsy.
Martin-McGill KJ; Bresnahan R; Levy RG; Cooper PN
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD001903. PubMed ID: 32588435
[TBL] [Abstract][Full Text] [Related]
11. Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders.
Spigoni V; Cinquegrani G; Iannozzi NT; Frigeri G; Maggiolo G; Maggi M; Parello V; Dei Cas A
Front Endocrinol (Lausanne); 2022; 13():972890. PubMed ID: 36339405
[TBL] [Abstract][Full Text] [Related]
12. Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Haghighatdoost F; Azadbakht L
Horm Metab Res; 2017 Sep; 49(9):687-692. PubMed ID: 28759939
[TBL] [Abstract][Full Text] [Related]
13. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restriction.
Risi R; Tozzi R; Watanabe M
Curr Opin Clin Nutr Metab Care; 2021 Jul; 24(4):349-353. PubMed ID: 33871418
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
[No Abstract] [Full Text] [Related]
15. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
Hannah WN; Harrison SA
Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
[TBL] [Abstract][Full Text] [Related]
16. Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review.
Parra-Vargas M; Rodriguez-Echevarria R; Jimenez-Chillaron JC
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33348700
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.
Hsu CC; Ness E; Kowdley KV
Adv Nutr; 2017 Mar; 8(2):253-265. PubMed ID: 28298270
[TBL] [Abstract][Full Text] [Related]
18. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
[TBL] [Abstract][Full Text] [Related]
19. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.
Moore MP; Cunningham RP; Davis RAH; Deemer SE; Roberts BM; Plaisance EP; Rector RS
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G564-G572. PubMed ID: 33501889
[TBL] [Abstract][Full Text] [Related]
20. A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD.
Moore MP; Cunningham RP; Dashek RJ; Mucinski JM; Rector RS
Obesity (Silver Spring); 2020 Oct; 28(10):1843-1852. PubMed ID: 32893456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]